Advertisement

Topics

Stallergenes Greer Announces Matthias Vogt as Chief Financial Officer

12:01 EDT 29 Jun 2017 | FinanzNachrichten

Regulatory News: Stallergenes Greer plc (Paris:STAGR) (Euronext Paris: STAGR), a biopharmaceutical company specializing in treatments for respiratory allergies, announced today the appointment of ...

Original Article: Stallergenes Greer Announces Matthias Vogt as Chief Financial Officer

NEXT ARTICLE

More From BioPortfolio on "Stallergenes Greer Announces Matthias Vogt as Chief Financial Officer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...